πŸ‡²πŸ‡½ Country Profile

Mexico

Fast-growing pharmaceutical trade with Mexico

πŸ‡²πŸ‡½ $450M
All data from DGCIS India export records (fiscal year, April–March).
$450M
Scale
Mexico's healthcare system receives $450M in Indian pharmaceutical products each year β€” affordable, quality medicine.
53%
Medicine
A diverse pharmaceutical mix: medicines, medicine ingredients, and vaccines each contributing significantly.
4.6Γ—
Trajectory
One of the faster-growing relationships β€” India's pharmaceutical supply to Mexico has expanded 4.6Γ— over the decade.
Context
Part of India's pharmaceutical supply network across Americas.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Mexico β€” building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicines $238M (53.0%) Medicine Ingredients $97.9M (21.8%) Vaccines $87.7M (19.5%) Surgical & Hospital Supplies $17.8M (4.0%) Traditional & Herbal $8.0M (1.8%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in Mexico Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Mexico: $46.2M across 51 filings (2011-2025).